Generics

Micro Labs, Saptalis debut generic Riomet

Riomet had a market value of $15 million in 2019, according to IQVIA.
Gilead strikes deal with 5 generic firms to expand remdesivir supply

Gilead has inked deals with Cipla, Ferozsons Laboratories, Hetero Labs, Jubilant Lifesciences and Mylan to manufacture remdesivir for distribution in 127 countries.
FDA approves Zydus Cadila's generic Exjade

Zydus Cadila’s generic Exjade is available in dosage strengths of 125 mg, 250 mg and 500 mg.
Fresenius Kabi debuts generic Mycamine

Fresenius Kabi’s first-to-market generic Mycamine provides a cost-effective option for treating certain infections.
American Regent debuts generic Cardene

American Regent's generic Cardene offers a treatment option for hypertension.
FDA gives tentative nod for Glenmark’s generic Qtern

Qtern tablets, 10 mg/5 mg had a market value of roughly $10.4 million for the 12 months ended February 2020, according to IQVIA.
Dr. Reddy's debuts generic DDAVP

The DDAVP (desmopressin acetate) injection brand and generic had a market value of approximately $20.9 million for the most recent 12 months ended March 2020, according to IQVIA.
Aurobindo gets FDA green light for generic Ancobon

Flucytosine capsules had a market value of roughly $43 million for the 12 months ended March 2020, according to IQVIA.

FDA gives tentative nod for Zydus Cadila's generic Northera